Evidence map›Paper›PMID 37576612›Full record

ArticleJournal of hepatocellular carcinoma2023

Integration of Multimodal Computed Tomography Radiomic Features of Primary Tumors and the Spleen to Predict Early Recurrence in Patients with Postoperative Adjuvant Transarterial Chemoembolization.

Cong Chen, Jian Liu, Zhuxin Gu, Yanjun Sun, Wenwu Lu, Xiaokan Liu, Kang Chen, Tianzhi Ma, Suming Zhao, Hui Zhao

Open access · goldAbstract read
In one paragraph

Article in Journal of hepatocellular carcinoma, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Cong Chen *Department of Interventional & Vascular Surgery, Affiliated Hospital of Nantong University, Nantong, 226001, People's Republic of China.ORCID 0000-0002-2158-1217
Jian Liu *Dalian Medical University and Affiliated Hospital of Nantong University, Nantong, 226001, People's Republic of China.
Zhuxin GuDepartment of Interventional & Vascular Surgery, Affiliated Hospital of Nantong University, Nantong, 226001, People's Republic of China.
Yanjun SunDepartment of Interventional & Vascular Surgery, Affiliated Hospital of Nantong University, Nantong, 226001, People's Republic of China.
Wenwu LuDepartment of Medical Ultrasound, Affiliated Hospital of Nantong University, Nantong, 226001, People's Republic of China.
Xiaokan LiuDepartment of Interventional Radiology, Affiliated Hospital 2 of Nantong University, Nantong, 226001, People's Republic of China.
Kang ChenDepartment of Interventional & Vascular Surgery, Affiliated Hospital of Nantong University, Nantong, 226001, People's Republic of China.
Tianzhi MaNanjing University of Aeronautics and Astronautics, Nanjing, 210000, People's Republic of China.
Suming ZhaoDepartment of Interventional & Vascular Surgery, Affiliated Hospital of Nantong University, Nantong, 226001, People's Republic of China.
Hui ZhaoDepartment of Interventional & Vascular Surgery, Affiliated Hospital of Nantong University, Nantong, 226001, People's Republic of China.
Nantong University · CNDalian Medical University · CNNanjing University of Aeronautics and Astronautics · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hepatocellular carcinoma (HCC) is one of the most lethal malignancies in the world. Patients with HCC choose postoperative adjuvant transarterial chemoembolization (PA-TACE) after surgical resection to reduce the risk of recurrence. However, many of them have recurrence within a short period. Methods: In this retrospective analysis, a total of 173 patients who underwent PA-TACE between September 2016 and March 2020 were recruited. Radiomic features were derived from the arterial and venous phases of each patient. Early recurrence (ER)-related radiomics features of HCC and the spleen were selected to build two rad-scores using the least absolute shrinkage and selection operator (LASSO) Cox regression analysis. Logistic regression was applied to establish the Radiation (Rad)_score by combining the two regions. We constructed a nomogram containing clinical information and dual-region rad-scores, which was evaluated in terms of discrimination, calibration, and clinical usefulness. Results: All three radiological scores showed good performance for ER prediction. The combined Rad_score performed the best, with an area under the curve (AUC) of 0.853 (95% confidence interval [CI], 0.783-0.908) in the training set and 0.929 (95% CI, 0.789-0.988) in the validation set. Multivariate analysis identified total bilirubin (TBIL) and the combined Rad_score as independent prognostic factors for ER. The nomogram was found to be clinically valuable, as determined by the decision curves (DCA) and clinical impact curves (CIC). Conclusion: A multimodal dual-region radiomics model combining HCC and the spleen is an independent prognostic tool for ER. The combination of dual-region radiomics features and clinicopathological factors has a good clinical application value.

Indexed as

computed tomographyhepatocellular carcinomanomogramradiomicstranscatheter arterial chemoembolization

Identifiers

PMID37576612
PMCPMC10422964
OpenAlexW4385660825

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.